News Focus
News Focus
icon url

williamssc

05/10/19 7:24 PM

#262883 RE: loanranger #262881

Noticed that too. So is ABSSSI P3 now where were headed.
icon url

kingofsting

05/10/19 7:24 PM

#262884 RE: loanranger #262881

“The Company is now engaged in activities necessary for beginning the Phase 3 study. Manufacturing of Brilacidin has been completed and is presently undergoing quality control and stability testing”

Awesome...super stoked...
icon url

williamssc

05/10/19 7:50 PM

#262889 RE: loanranger #262881

Well that was some backward look. ABSSSSI is no more it seems. Really disappointing. Onward with B-OM, B-UP.
icon url

Empiricst1

05/10/19 9:32 PM

#262917 RE: loanranger #262881

Thank, LL, fast dd; woaa, this will cost lots and lots. Will be worth it when there is money, but will not be cheap. Wonder why FDA want so big of a study? Almost like they are protecting daptomycin, though I don't really believe that. On the other hand, the B franchise could be stretched to lots of other uses, so maybe in anticipation of that FDA is making sure there are no latent side effect issues (to the extent any P-3 can). Once upon a time the side effect issue was hacked back and forth on this and the Yahoo Finance board quite a bit.